@misc{indiciaeaeafa141a7f9,
  title = {Atazanavir is a competitive inhibitor of SARS-CoV-2 Mpro, impairing variants replication in vitro and in vivo},
  author = {Chaves, O. A. and Sacramento, C. Q. and Ferreira, A. C. and Mattos, M. and Fintelman-Rodrigues, N. and Temerozo, J. R. and Pinto, D. P. and da Silveira, G. P. E. and da Fonseca, L. B. and Pereira, H. M. and Carlos, A. S. and d'Avila, J. d. C. P. and Viola, J. P. B. and Monteiro, R. Q. and Vazquez, L. and Bozza, P. T. and Castro-Faria-Neto, H. C. and Souza, T. M. L.},
  year = {2021},
  doi = {10.1101/2021.11.24.469775},
  url = {https://www.biorxiv.org/content/10.1101/2021.11.24.469775v1},
  note = {Source identifier: 10.1101/2021.11.24.469775}
}